VaxInnate Corporation vaxinnate.com


Public lists: Pharma Startups (4740)

VaxInnate is a privately-held biotechnology company in Cranbury, NJ that is developing a technology platform for use in developing novel and proprietary vaccines. VaxInnate's vaccines focus on infectious diseases, including seasonal and pandemic flu, dengue, and Clostridium difficile. VaxInnate's technology has the potential to dramatically improve the potency, manufacturing capacity and cost-effectiveness of vaccines. VaxInnate has already generated positive Phase 1, and in some instances Phase...Show all

VaxInnate is a privately-held biotechnology company in Cranbury, NJ that is developing a technology platform for use in developing novel and proprietary vaccines. VaxInnate's vaccines focus on infectious diseases, including seasonal and pandemic flu,...Show all

Company (Dead / Inactive)

Phone: 609-860-2260

Fax:

3 Cedar Brook Drive
Suite 1
Cranbury, 08512
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
VaxInnate Corporation $104.5M Feb 1, 2017
Iomai Corporation $115.4M Aug 25, 2008
Lofarma S.p.A. $0M Mar 20, 2019
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related VaxInnate Corporation Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods of stimulating immunity employing dengue viral antigens Dec 01, 2015 Sep 20, 2016 Patent
Methods of stimulating protective immunity employing dengue viral antigens Sep 23, 2014 Jan 12, 2016 Patent
Deletion mutants of flagellin and methods of use Dec 17, 2014 Dec 15, 2015 Patent
Deletion mutants of flagellin and methods of use Dec 16, 2014 Dec 08, 2015 Patent
Flagellin fusion proteins Dec 10, 2014 Dec 01, 2015 Patent
See all 18 patents